Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025)
Nano-X Imaging (NNOX) posted quarterly Cash from Financing Activities of $15.5 million for Q4 2025, down 59.01% year-on-year from $37.8 million in Q4 2024, and up 170.35% on a QoQ basis from $5.7 million in Q3 2025.
Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Nano-X Imaging (NNOX) has reported Cash from Financing Activities for 5 consecutive years, with $15.5 million the latest figure, recorded in Q4 2025.
- Quarterly Cash from Financing Activities fell 59.01% year-over-year to $15.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.4 million (down 45.91% YoY) and the FY2025 annual result came in at $21.4 million, down 45.91% from the prior year.
- Cash from Financing Activities improved to $15.5 million in Q4 2025 per NNOX's latest filing, from $5.7 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for NNOX reached as high as $37.8 million in Q4 2024 and fell as low as -$12.0 million in Q2 2021.
- A 5-year average of $5.1 million and a median of $176000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities sank 368.84% — and 2024, when it surged 114560.61%.
- Year by year, Cash from Financing Activities stood at $1.0 million in 2021, then sank by 83.33% to $174000.0 in 2022, then slumped by 81.03% to $33000.0 in 2023, then jumped by 114560.61% to $37.8 million in 2024, then tumbled by 59.01% to $15.5 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $15.5 million, $5.7 million, and $121000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.51 Mn |
| Dec 31, 2025 | 15.51 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 121,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 37.84 Mn |
| Dec 31, 2024 | 37.84 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 27.41 Mn |
| Sep 30, 2023 | 27.41 Mn |
| Jun 30, 2023 | -371,000.00 |
| Jun 30, 2023 | -371,000.00 |